Read the latest positive news, breakthroughs, and inspiring stories about hpv vaccine, curated daily by BrightWire.
Nigeria's health agency revealed that 93% of children in recent diphtheria outbreaks hadn't received full vaccinations, sparking a nationwide push to combat misinformation. Meanwhile, the country celebrates vaccinating over 18 million girls against HPV and reaching 102 million children with measles protection.
New research reveals that 2.3 million cancer cases globally could be prevented through existing vaccines and treatments for common infections. Simple interventions could stop millions of cancers before they ever start.
Scientists now know that roughly 1 in 8 cancer cases worldwide come from infections we can already prevent or treat. Vaccines, screening, and simple treatments could stop millions of these cancers before they ever develop.
New research reveals that infections cause 12% of all cancer cases worldwide, and many could be prevented with vaccines we already have. Countries with high HPV vaccination rates are seeing cancer cases disappear entirely in young adults.
Kenya nearly doubled its HPV vaccination rate in 2026, protecting hundreds of thousands of adolescent girls from cervical cancer. The success story shows what's possible when governments invest in prevention programs that save lives.
A generation of Australian women vaccinated against HPV as teens is now seeing cervical cancer nearly vanish. Among women in their late twenties, cases have dropped 95% in just over a decade.
West Bengal is partnering with a pioneering sex workers' collective to provide free HPV vaccines in Kolkata's Sonagachi, targeting one of the most vulnerable groups for cervical cancer. The program honors three decades of community-led health advocacy.
For the first time ever, zero women in their early 20s died from cervical cancer in England over a four-year period. Scientists credit the HPV vaccine with reducing cervical cancer death risk before age 30 to "effectively zero."
Young women vaccinated against HPV at age 12-13 now have close to zero risk of dying from cervical cancer before 30. A landmark study from England shows the vaccine has already saved around 200 lives since 2008.
Kenya is launching new action plans to eliminate cervical cancer deaths, drawing inspiration from England's HPV vaccine success. With fresh funding and partnerships, the country aims to reach every woman and girl with preventive care.
Young women who get the HPV vaccine in their early teens have virtually no risk of dying from cervical cancer before age 30. This groundbreaking research proves the vaccine is even more life-saving than scientists initially believed.
For the first time ever, zero women aged 20-24 died from cervical cancer in the UK over a five-year period, thanks to routine HPV vaccination. Without the vaccine, 23 deaths would have been expected during that time.